In Korea, the second most common cause of death is stroke, and the treatment and management of cerebrovascular diseases incurs a large financial burden[@b1][@b2]. Many stroke patients receive traditional medical care in Korea. According to a recent report from the Korean Ministry of Health and Welfare, stroke inpatients comprise the largest proportion of inpatients in traditional Korean medicine (TKM) hospitals[@b3].

PI is a traditional diagnostic system characterized by its own theoretical basis and practical experience in traditional Eastern-Asian medicine (TEAM), which is practiced in China, Korea and Japan[@b4][@b5][@b6][@b7]. PI is the foundation of the treatment disease in TEAM. In traditional Chinese medicine (TCM), stroke is classified into six subtypes according to PI, and Zhou *et al*. reported the efficacy of therapies based on PI among patients with cerebral infarction[@b8].

PI diagnosis is processed by the combination of signs and symptoms that are, specific and/or non-specific for diseases through observation, listening, questioning and feeling the pulse[@b9].

However, the PI diagnosis exhibits limited objectivity and reproducibility due to the lack of standardized measurement indices, and it is difficult to objectify a diagnosis among physicians due to variations in their knowledge and experience[@b4][@b5][@b6][@b10]. As the demand for the reestablishment and development of TKM has increased, studies on the establishment of a scientific basis for and the standardization of PI have been actively conducted[@b7].

The Korea Institute of Oriental Medicine (KIOM) conducted the project "Fundamental study for the standardization and objectification of pattern identification in TKM for stroke (SOPI-Stroke)" over the course of nine years from April 2005 to December 2013[@b5][@b6].

The purpose of this paper was to evaluate the distribution and characteristics of several key factors, including demographic parameters, lifestyle factors, symptoms/signs, stroke etiology, medical history, and laboratory results, in relation to the PI of stroke patients in TKM according to the results of the SOPI-Stroke project.

Results
=======

Stroke etiology in relation to PI
---------------------------------

Of the 4921 stroke patients collected over nine years, 3466 patients received the same PI diagnosis by two TKM experts with the following distribution: Qi-Deficiency (QD) pattern (n = 810, 23.37%), Fire-Heat (FH) pattern (n = 1031, 29.75%), Dampness-Phlegm (DP) pattern (n = 1127, 32.52%), and Yin-Deficiency (YD) pattern (n = 498, 14.37%). The different stroke types and NIHSS scores in relation to PI are presented in [Table 1](#t1){ref-type="table"}. Approximately 89.9% of subjects enrolled in this study had cerebral infarction (CI). In the TOAST classification of CI type, many subjects exhibited small vessel occlusion (SVO) rather than large artery atherosclerosis (LAA). The NIHSS score of the majority of patients was below 15. Among PI, the frequency of CI and SVO in the DP pattern was slightly higher than the YD pattern, but the NIHSS score among PI was not different.

Distribution of symptoms/signs in relation to PI
------------------------------------------------

The Korean standard PI (K-SPI) of stroke consists of four PIs (QD, FH, DP, and YP pattern), and a total of 44 symptoms/signs for determining PI were reported in a previous study[@b6]. Variables are classified into four types: 19 FH variables, 7 DP variables, 11 QD variables, and 11 YD variables. [Table 2](#t2){ref-type="table"} shows the distribution of the variables according to PI. In the FH pattern, headache-like flush, red tongue and strong pulse were the major symptoms. In the DP pattern, obesity (bi-sup) and a white "fur" on the tongue were common. Appearing powerless and lethargic and weak pulse symptoms were commonly observed in the QD pattern. Tidal fever, dry mouth and gauntness were more common in the YD pattern than in other PIs.

Physical characteristics and lifestyle parameters in relation to PI
-------------------------------------------------------------------

[Table 3](#t3){ref-type="table"} shows the physical characteristics and lifestyle patterns in relation to PIs. The BMI and WHR, which are related with obesity, were higher in the DP pattern than in other PIs. For lifestyle patterns, subjects that were currently smokers and drinkers were more likely to exhibit the FH pattern than the QD or YD pattern. Food preferences were also different according to PI.

Medical history in relation to PI
---------------------------------

The subjects' medical histories are presented in [Table 4](#t4){ref-type="table"}. With regard to past medical history, more than 58% of the patterns showed hypertension, which was the most common (58.43--63.35%) disease. A stroke-related history of diseases such as hypertension, DM, and heart attack was observed. However, the distribution among PIs was not different.

Blood parameters in relation to PI
----------------------------------

The subjects' blood parameters are presented in [Table 5](#t5){ref-type="table"}. In the haematology category, the levels of WBC, hemoglobin and hematocrit were higher in the FH pattern than in the other PIs. The platelet level was higher in the DP pattern, and the serum levels of lipids, including total cholesterol and triglycerides, were higher in the DP pattern compared to the other groups. Homocysteine and vitamin B12, which are indirect indicators of stroke, showed a different tendency among the pattern groups. The levels of homocysteine were higher in the FH group compared to the other groups, but the level of vitamin B12 was higher in the YD group.

Discussion
==========

In the practice of TEAM, including TCM and TKM, a unique decision-making process called Bian Zheng Lun Zhi (PI or syndrome differentiation followed by treatment) is widely used[@b11]. This method, also called traditional Chinese medical diagnostics, is the procedure and practice of examining patients, determining diseases and differentiating syndromes/identifying patterns of signs and symptoms of diseases[@b4]. Through the comprehensive analysis of symptoms and signs, which has implications in determining the cause, nature and location of the illness and the patient's physical condition, their treatment is determined and confirmed[@b4][@b11]. According to TEAM theory, even patients with the same disease receive different treatments based on PI results. Although this diagnostic system has many advantages in that it uses a comprehensive analysis of symptoms and signs to assess the cause of the diseases, there are many variations in the diagnostic process[@b7][@b12].

KIOM focuses on the importance of standardization in PI and has been engaged in relevant research[@b7]. The SOPI-Stroke project was conducted by KIOM from April 2005 to December 2013 to standardize and objectify PI for stroke through a scientific process[@b5][@b6][@b10]. In a previous study, our team described the four standard patterns, FH pattern, DP pattern, YD pattern, and QD pattern, in stroke and the forty-four indices used to determine the pattern[@b6]. This paper provides the characteristics, laboratory results and symptoms and signs of stroke patients who were treated according to TKM in the SOPI-Stroke project.

Among the symptoms/signs for PI diagnosis, some were common in each of the types of PI ([Table 2](#t2){ref-type="table"}). Over 80% of subjects with the FH pattern exhibited a reddened complexion, red tongue and a strong pulse. A white "fur" on the tongue and obesity (bi-sup) were major symptoms in the DP pattern, and many patients with the QD pattern appeared powerless and lethargic and had a weak pulse pattern. The YD pattern was associated with paleness, a red zygomatic site and dry mouth. These results were similar to other studies presented by our team and other TCM researchers[@b13][@b14].

Many previous studies were performed to evaluate the relationship between Western indicators, such as body composition or blood parameters, and PI patterns[@b15][@b16][@b17][@b18][@b19]. [Tables 3](#t3){ref-type="table"} and [5](#t5){ref-type="table"}, respectively, show the distribution of body composition and blood parameters among PI. Among these, the level of obesity indices, including BMI and waist circumference, were significantly higher in the DP and FH patterns than in the QD and YD patterns ([Table 3](#t3){ref-type="table"}). Total cholesterol, triglycerides and total lipids, which are blood parameters positively related to obesity, were also higher in the DP and FH ([Table 5](#t5){ref-type="table"}). These results are similar to those previously reported by Min *et al*.[@b15], and other studies showed that DP was significantly related to the obese phenotype[@b16][@b17][@b18].

Genetic studies showed that many of the gene polymorphisms were related to obesity and obese phenotypes[@b20][@b21][@b22][@b23]. Similar studies that show the association between genetic polymorphisms and PI were performed in TKM and TCM[@b17][@b24][@b25][@b26]. Specifically, the polymorphisms in UCP2 and UCP3, which were significantly associated with BMI and serum cholesterol in Korean female subjects, were also associated with DP pattern[@b24][@b27][@b28]. Some studies showed controversial results. For example, Kim *et al*. reported that subjects with the C allele of −607 G \> C in wnt10b had lower BMI levels than subject with the GG type[@b29], but Ko *et al*. showed that the −607 G \> C polymorphism was related to the YD pattern, not DP pattern[@b25]. Those results suggested that the PI, a diagnostic system used in TEAM, exhibited similar or different phenotypes compared to the phenotypes discussed in Western medicine.

There are some limitations to our study. To obtain the characteristics of stroke patients treated with TKM, observational studies are very important. This is a potentially interesting observational study because it provided evidence for clinical practice. This paper describes the baseline characteristics of stroke according to PI but there is no follow-up data describing long-term outcomes. Therefore, it is necessary to conduct improved randomized controlled trial studies or cohort studies to obtain reliable results on PI phenotypes and the effect of treatment based on PI compared with Western medicine. Second, the population enrolled in this study focused on the CI type and SVO type according to the TOAST classification. Additionally, the severity of stroke in the enrolled patients was lower than that of stroke patients visiting Western medical hospitals. For this reason, it is difficult to generalize the characteristics of PI. TKM uses four methods of diagnosis, which include diagnosis by observation, hearing and smelling, interrogation, and palpation. Diagnosis depends on the clinician's experience and knowledge, along with a variety of environmental factors. It is essential to establish an objective diagnostic standard for tongue and pulse measurements, along with other reliable diagnostic tools.

Although this study had some limitations, the significance of our study was to show the characteristics of the patients receiving TKM treatment. In TKM treatment, PI comprises a series of processes that involve not only identifying specific neurological symptoms but also unspecific symptoms and indicators with four examinations, as well as determining treatment goals after integrating all the data for stroke diagnosis. These results should to lead to the standardization of PI for stroke in TKM.

Methods
=======

Subjects
--------

This study was a community-based multicentre trial that was part of the SOPI-Stroke project[@b5][@b6]. Stroke patients who were admitted to 15 TKM university hospitals participated in this study from 2005 through 2013 (The entire list of hospitals can be found as [Supplementary Table S1](#S1){ref-type="supplementary-material"}). Each patient provided written informed consent to undergo procedures that were approved by the respective institutions' Institutional Review Boards (IRB). This study was conducted in accordance with approved guidelines by the IRB of the KIOM and by each TKM university hospital's IRB. All patients provided informed consent after a thorough explanation of the details. [Figure 1](#f1){ref-type="fig"} shows the PI distribution among stroke patients by gender according to region.

Inclusion/exclusion criteria
----------------------------

We enrolled stroke patients within 30 days of the onset of their symptoms if their diagnosis was confirmed by an imaging diagnosis such as computerized tomography (CT) or magnetic resonance imaging (MRI)[@b5][@b6]. Patients with traumatic stroke such as subarachnoid, subdural, and epidural haemorrhage were excluded from the study. This study was approved by the IRB of the KIOM and by each TKM university hospital's IRB.

Measured variables
------------------

Each patient was seen by two experts in the same department within each site. All experts were well trained in standard operation procedures (SOPs). The experts had at least three years of clinical experience with stroke after finishing a regular college education of TKM for six years. The examination parameters were extracted from parts of a case report form (CRF) for the standardization of stroke diagnosis developed by an expert committee organized by the KIOM. The measured variables used included the following key subjects in relation to PI: (a) stroke etiology; (b) distribution of signs/symptoms; (c) physical characteristics and lifestyle parameters; (d) medical history; and (e) laboratory results. Specifically, as suggested by the KIOM, the clinicians were required to measure the stroke PI of each patient according to the FH pattern, DP pattern, QD pattern, or YD pattern.

Statistics
----------

Data were statistically analysed with SAS software, version 9.1.3 (SAS Institute Inc., Cary, NC, USA). Categorical variables were compared with the chi-square test or Fisher's exact test, and differences in continuous variables were determined by one-way analysis of variance (ANOVA). Statistical significance was set at P \< 0.05.
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###### Stroke etiology among pattern identification of study subjects.

  Characteristics                                    Pattern identification      P value                                                     
  ------------------------------------------------- ------------------------ --------------- --------------- --------------- --------------- ----------
  Number of patients                                       3466 (100)          810 (23.37)    1031 (29.75)    1127 (32.52)     498 (14.37)        
  Age (yrs), Mean ± SD                                   67.23 ± 11.49        67.93 ± 12.05   65.94 ± 11.29   66.48 ± 11.11   70.50 ± 11.14   \<0.0001
  Gender                                                                                                                                     
   Male                                                   1814 (52.34)         297 (36.67)     748 (72.55)     541 (48.00)     228 (45.78)    \<0.0001
   Female                                                 1652 (47.66)         513 (63.33)     283 (27.45)     586 (52.00)     270 (54.22)        
  Stroke subtype                                                                                                                             
   ICH[1](#t1-fn1){ref-type="fn"}                          302 (8.72)           65 (8.02)      101 (9.80)       86 (7.63)      50 (10.04)      0.0229
   SAH[1](#t1-fn1){ref-type="fn"}                          20 (0.58)            11 (1.36)       3 (0.29)        4 (0.35)        2 (0.40)          
   CI                                                     3114 (89.92)         723 (89.26)     922 (89.43)    1027 (91.13)     442 (88.76)        
   other subtype                                           27 (0.78)            9 (1.11)        4 (0.39)        10 (0.89)       4 (0.80)          
  TOAST classification                                                                                                                       
   LAA                                                    762 (24.64)          153 (21.16)     252 (27.33)     231 (22.49)     126 (28.51)     0.0167
   CE                                                      179 (5.79)           41 (5.67)       59 (6.40)       51 (4.97)       28 (6.33)         
   SVO                                                    1990 (64.36)         481 (66.53)     565 (61.28)     684 (66.60)     260 (59.14)        
   SOE                                                     46 (1.49)            12 (1.66)       8 (0.87)        17 (1.66)       9 (2.04)          
   SUE                                                     111 (3.59)           27 (3.73)       28 (3.04)       39 (3.80)       17 (3.85)         
   other subtype                                            4 (0.13)            3 (0.41)        1 (0.11)            0               0             
  Baseline NIHSS score[1](#t1-fn1){ref-type="fn"}                                                                                            
   \<15                                                   2694 (97.57)         563 (97.24)     772 (96.74)     981 (98.30)     378 (97.93)     0.1706
   ≥15                                                     67 (2.43)            16 (2.76)       26 (3.26)       17 (1.70)       8 (2.07)          
  Onset mode of stroke[1](#t1-fn1){ref-type="fn"}                                                                                            
   On awakening; sleep                                    644 (22.04)          149 (23.39)     191 (22.90)     211 (20.29)     93 (22.63)      0.4055
   Awake                                                  2018 (69.06)         433 (67.97)     577 (69.18)     735 (70.67)     273 (66.42)        
   Unknown                                                 260 (8.90)           55 (8.63)       66 (7.91)       94 (9.04)      45 (10.95)         

All results except age are expressed as frequencies (percentages) for categorical variables. QD: qi deficiency pattern. FH: fire-heat pattern. YD: yin deficiency pattern. DP: dampness phlegm pattern. ICH: intracerebral hemorrhage. SAH: subarachnoid hemorrhage. CI: cerebral infarction. TOAST: Trial of ORG 10172 in Acute Stroke Treatment. LAA: large-artery atherosclerosis. CE: cardioembolism. SVO: small-vessel occlusion. SOE: stroke of other etiology. SUE: stroke of undetermined etiology. NIHSS: National Institutes of. Health Stroke Scale.

^1^collected data from June 2005 to April 2011. P values were calculated by ANOVA in continuous variables, chi-squared test in categorical variables.

###### Distribution of Korean standard pattern identification for stroke III of study subjects.

             Characteristics                       Pattern identification     P value                                                
  ---------- ------------------------------------ ------------------------ ------------- -------------- -------------- ------------- ----------
             Number of patients                          3466 (100)         810 (23.37)   1031 (29.75)   1127 (32.52)   498 (14.37)       
  FH index   Reddened complexion                        1074 (64.19)        89 (30.79)    658 (84.35)    206 (53.78)    121 (54.75)   \<0.0001
             Headache like flush                        184 (16.21)         50 (16.61)     80 (22.03)     26 (8.30)     28 (17.72)    \<0.0001
             Heat vexation and aversion to heat         1387 (40.34)        241 (30.08)   562 (55.09)    394 (35.14)    190 (38.30)   \<0.0001
             Heat vexation in the chest                 464 (29.23)         92 (23.17)    191 (37.45)    106 (25.17)    75 (28.95)    \<0.0001
             Vexation and insomnia                      496 (29.33)         94 (23.91)    216 (38.70)    113 (24.14)    73 (26.83)    \<0.0001
             Thirst                                     1170 (34.17)        231 (28.66)   433 (42.87)    314 (28.11)    192 (39.10)   \<0.0001
             Wheezing in throat with sputum             689 (23.12)         123 (17.47)   219 (24.97)    258 (26.00)    89 (21.92)    \<0.0001
             Blood-shot eyes                            1570 (45.74)        385 (48.42)   459 (44.82)    510 (45.57)    216 (43.72)    0.3233
             Aphtha or tongue sore                       187 (5.83)          34 (4.55)     60 (6.048)     59 (5.86)      34 (7.40)     0.2249
             Vexing heat in the extremities              314 (9.87)          39 (5.27)    137 (14.03)     100 (9.89)     38 (8.35)    \<0.0001
             Heat in the palms and soles                 318 (9.93)          31 (4.17)    135 (13.69)     90 (8.91)     62 (13.41)    \<0.0001
             Turbid urine                               769 (26.05)         164 (23.39)   272 (31.81)    221 (23.73)    112 (24.13)   \<0.0001
             Fetid mouth odor                           718 (21.78)         110 (14.55)   271 (27.07)    258 (24.02)    79 (16.98)    \<0.0001
             Yellow fur on tongue                       1045 (61.18)        137 (41.76)   458 (71.11)    329 (67.00)    121 (49.38)   \<0.0001
             Thick fur on tongue                        1238 (57.07)        183 (43.88)   447 (60.32)    506 (68.93)    102 (36.82)   \<0.0001
             Red tongue                                 1164 (69.49)        171 (53.27)   525 (80.52)    219 (56.01)    249 (80.06)   \<0.0001
             Strong pulse                               1205 (68.97)        116 (47.73)   546 (80.05)    429 (71.26)    114 (51.81)   \<0.0001
             Surging pulse                               295 (8.72)          24 (3.05)    190 (18.75)     61 (5.53)      20 (4.14)    \<0.0001
             Rapid pulse                                1030 (65.43)        125 (49.80)   393 (71.32)    333 (65.94)    179 (67.04)   \<0.0001
  DP index   Sallow complexion                          1014 (55.40)        201 (52.48)   147 (33.56)    562 (73.17)    104 (43.15)   \<0.0001
             (Physique)heaviness (*bi-sup*)             728 (58.56)         83 (42.13)    211 (56.11)    375 (75.45)    59 (34.10)    \<0.0001
             Dark inferior palpebral                    515 (14.91)         115 (14.21)    98 (9.57)     240 (21.33)    62 (12.47)    \<0.0001
             Dizziness with nausea                      644 (18.95)         148 (18.66)   173 (17.12)    230 (20.81)    93 (19.01)     0.1931
             Enlarged tongue                            495 (35.50)         113 (34.55)   111 (25.81)    227 (51.70)    44 (22.22)    \<0.0001
             White fur on tongue                        1754 (78.12)        456 (78.89)   405 (68.64)    698 (88.13)    195 (68.42)   \<0.0001
             Slippery pulse                             1425 (41.92)        165 (20.96)   365 (35.96)    789 (71.01)    106 (21.81)   \<0.0001
  QD index   Pale complexion                            518 (38.20)         326 (66.39)    49 (13.49)     93 (30.39)    50 (25.51)    \<0.0001
             Look powerless and lazy                    1713 (49.43)        634 (78.36)   349 (33.85)    461 (40.90)    269 (54.01)   \<0.0001
             Feel powerless and lazy                    1651 (47.92)        561 (69.68)   366 (35.77)    473 (42.23)    251 (50.50)   \<0.0001
             Reluctance to speak                        1044 (30.29)        423 (52.61)   216 (21.11)    256 (22.79)    149 (30.04)   \<0.0001
             Drowsiness, likes to lie down              954 (35.91)         359 (57.34)   211 (26.74)    249 (28.91)    135 (35.52)   \<0.0001
             Reversed cold in the extremities           448 (13.98)         156 (20.82)    88 (9.05)     132 (12.89)    72 (15.68)    \<0.0001
             Pale tongue                                912 (60.23)         294 (69.01)   154 (38.30)    385 (77.77)    79 (41.36)    \<0.0001
             Teeth-marked tongue                        487 (34.91)         156 (42.62)    98 (23.38)    186 (44.81)    47 (24.10)    \<0.0001
             Weak pulse                                 931 (61.86)         403 (82.58)   119 (36.06)    246 (57.88)    163 (62.21)   \<0.0001
             Fine pulse                                 671 (19.79)         304 (38.48)    74 (7.31)      110 (9.96)    183 (37.80)   \<0.0001
             Slow pulse                                 552 (44.84)         212 (64.04)    81 (26.38)    203 (49.63)    56 (30.43)    \<0.0001
  YD index   Pale face and red zygomatic-site           417 (35.36)         53 (20.62)    126 (33.24)     74 (26.81)    164 (61.42)   \<0.0001
             Tidal fever                                 295 (8.63)          53 (6.64)    103 (10.15)     64 (5.75)     75 (15.21)    \<0.0001
             (Physique) gauntness (*so-su*)             408 (40.39)         105 (52.5)    131 (38.52)     65 (23.89)    107 (54.04)   \<0.0001
             Night sweating                             586 (16.94)         120 (14.86)   191 (18.59)    155 (13.76)    120 (24.09)   \<0.0001
             Dry mouth                                  1719 (50.21)        386 (48.06)   545 (53.74)    474 (42.54)    314 (63.82)   \<0.0001
             Bare and red tongue like a mirror          156 (14.51)         28 (11.11)     43 (11.81)     11 (4.43)     74 (35.07)    \<0.0001
             Dry fur on tongue                          676 (37.24)         116 (31.43)   242 (38.59)    165 (33.06)    153 (47.81)   \<0.0001

All results are expressed as frequencies (percentages) for categorical variables. The frequency analysis was performed by converting pattern identification index measurements from the 3-point scale in which 3 = very much, 2 = much, or 1 = not much to a 2-point scale (yes or no). P values were calculated by chi-squared test.

###### Physical characteristics and lifestyle parameters of study subjects.

  Characteristics                              Pattern identification         P value                                                                            
  ------------------------------------------- ------------------------ --------------------- --------------------- ---------------------- ---------------------- ----------
  Weight (kg), N (Mean ± SD)                    3079 (61.66 ± 10.91)    709 (56.92 ± 9.65)    906 (64.79 ± 10.12)   1034 (64.10 ± 10.85)   430 (57.06 ± 10.40)    \<0.0001
  Height (cm)                                   2987 (160.69 ± 9.15)    682 (158.15 ± 8.59)   881 (163.77 ± 8.32)   1005 (160.60 ± 8.74)   419 (158.58 ± 10.65)   \<0.0001
  BMI (kg/m^2^)                                 2959 (23.82 ± 3.23)     673 (22.67 ± 3.05)    872 (24.16 ± 2.89)    1001 (24.81 ± 3.24)     413 (22.57 ± 3.20)    \<0.0001
  Waist circumference (cm)                      2290 (87.00 ± 9.42)     509 (84.62 ± 8.82)    649 (88.10 ± 9.00)     806 (88.95 ± 9.52)     326 (83.74 ± 9.28)    \<0.0001
  Hip circumference (cm)                        2207 (93.21 ± 8.89)     493 (91.92 ± 8.39)    622 (93.81 ± 8.69)     778 (94.50 ± 8.80)     314 (90.87 ± 9.57)    \<0.0001
  WHR                                           2203 (0.935 ± 0.084)    491 (0.923 ± 0.086)   622 (0.942 ± 0.084)   776 (0.941 ± 0.069)    314 (0.928 ± 0.110)    \<0.0001
  Marital status[1](#t3-fn1){ref-type="fn"}                                                                                                                      
   Married/cohabiting                               2069 (71.32)            406 (50.12)           660 (64.02)           725 (64.33)            278 (55.82)        \<0.0001
   Never married                                     62 (2.14)               12 (1.48)             18 (1.75)             22 (1.95)              10 (2.01)             
   Divorced/separated                                63 (2.17)               16 (1.98)             20 (2.42)             24 (2.13)               3 (0.60)             
   Widowed                                          707 (24.37)             196 (24.20)           129 (12.51)           263 (23.34)            119 (23.90)            
  Stress                                                                                                                                                         
   Bereaved of the Spouse                            24 (0.70)               8 (0.99)              5 (0.48)               5 (0.44)               6 (1.20)          0.2678
   Economic loss                                     202 (5.68)              37 (4.57)             58 (5.63)             81 (7.19)              26 (5.22)             
   Other stress                                     796 (23.13)             185 (22.84)           241 (23.38)           255 (22.63)            115 (23.09)            
   None                                             2420 (70.31)            575 (70.99)           718 (69.64)           778 (69.03)            349 (70.08)            
  Religion                                                                                                                                                       
   Yes                                              1620 (55.84)            401 (63.65)           398 (48.13)           604 (58.41)            217 (52.93)        \<0.0001
   No                                               1846 (44.16)            229 (36.35)           429 (51.87)           430 (41.59)            193 (47.07)            
  Smoking status                                                                                                                                                 
   Current smoker                                   1010 (29.22)            184 (22.72)           382 (37.05)           316 (28.04)            128 (25.70)        \<0.0001
   Former smoker                                    584 (16.90)             106 (13.09)           233 (22.60)           167 (14.82)             78 (15.66)            
   Never smoker                                     1862 (53.88)            518 (63.95)           414 (40.16)           640 (56.79)            290 (58.23)            
  Drinking status                                                                                                                                                
   Current drinker                                  1223 (35.38)            234 (28.89)           460 (44.62)           366 (32.48)            163 (32.73)        \<0.0001
   Former drinker                                   381 (11.02)              71 (8.77)            150 (14.55)            110 (9.76)             50 (10.04)            
   Never drinker                                    1853 (53.60)            503 (62.10)           419 (40.64)           647 (57.41)            284 (57.03)            
  Exercise                                                                                                                                                       
   Yes                                              1243 (39.17)            286 (35.31)           389 (37.73)           409 (36.29)            159 (31.93)         0.3038
   No                                               1930 (55.68)            443 (54.69)           562 (54.51)           637 (56.52)            288 (57.83)            
  Food preference^&^                                                                                                                                             
   Meat (Yes, %)                                    1448 (44.57)            281 (34.69)           493 (47.82)           487 (43.21)            187 (37.55)        \<0.0001
   Sea food (Yes, %)                                1624 (47.51)            335 (41.36)           519 (50.34)           554 (49.16)            216 (43.37)        \<0.0001
   Fast food (Yes, %)                               1805 (52.89)            440 (54.32)           489 (47.43)           631 (55.99)            245 (49.20)        \<0.0001

All results except weight, height, BMI, waist circumference, and hip circumference are expressed as frequencies (percentages) for categorical variables. BMI: body mass index. WHR: waist-hip ratio. ^&^Replied 'very like 'or 'like'.

^1^Collected data from June 2005 to April 2011. P values were calculated by ANOVA in continuous variables, chi-squared test in categorical variables. The sum of N does equal the total number of patients for all variables because some items had missing data.

###### Medical history of study subjects.

  Characteristics                                                                       Pattern identification     P value                                                
  ------------------------------------------------------------------------------------ ------------------------ ------------- -------------- -------------- ------------- ----------
  Number of patients                                                                          3466 (100)         810 (23.37)   1031 (29.75)   1127 (32.52)   498 (14.37)       
  Past medical history                                                                                                                                                    
   TIA (Yes, %)                                                                               262 (7.56)          54 (6.67)     75 (7.27)      85 (7.54)      48 (9.64)     0.2918
   Facial palsy[1](#t4-fn1){ref-type="fn"} (Yes, %)                                           196 (6.77)          36 (5.74)     68 (8.23)      64 (6.20)      28 (6.91)     0.2220
   Hypertension (Yes, %)                                                                     2092 (60.67)        475 (58.64)   612 (59.36)    714 (63.35)    291 (58.43)    0.1084
   Hyperlipidemia (Yes, %)                                                                   466 (13.64)         114 (14.07)   135 (13.09)    166 (14.73)    51 (10.24)     0.1063
   Diabetes mellitus (Yes, %)                                                                924 (26.84)         221 (27.28)   270 (26.19)    320 (28.39)    113 (22.69)    0.1148
   Ischemic heart disease (Yes, %)                                                            200 (5.85)          54 (6.67)     48 (4.66)      66 (5.86)      32 (6.43)     0.2699
   Depression[1](#t4-fn1){ref-type="fn"} (Yes, %)                                             103 (3.56)          35 (5.58)     26 (3.15)      31 (3.00)      11 (2.72)     0.0208
   Migraine[1](#t4-fn1){ref-type="fn"} (Yes, %)                                              316 (10.91)         81 (12.86)     98 (11.91)     92 (8.91)     45 (11.08)     0.0569
   Stroke[1](#t4-fn1){ref-type="fn"} (Yes, %)                                                590 (20.29)         131 (20.79)   152 (18.31)    225 (21.66)    82 (20.05)     0.3453
   Infectious disease[1](#t4-fn1){ref-type="fn"} (Yes, %)                                    304 (10.42)          59 (9.29)     98 (11.78)     81 (7.81)     66 (15.98)    \<0.0001
   Antithrombotic, anticoagulant therapy (Yes, %)                                            1125 (33.34)        256 (31.60)   318 (30.84)    378 (33.54)    173 (34.74)    0.3210
   (Female) HRT experience[1](#t4-fn1){ref-type="fn"} (Yes, %)                                46 (3.58)           15 (3.99)      8 (4.15)      14 (2.74)      9 (4.41)      0.6119
   (Female) Intake of an oral contraceptive pill[1](#t4-fn1){ref-type="fn"} (Yes, %)           5 (0.62)           3 (1.12)        0 (0)         2 (0.63)        0 (0)       0.4676

All results are expressed as frequencies (percentages) for categorical variables. TIA: transient ischemic attack. HRT: hormone replacement therapy.

^1^Collected data from June 2005 to April 2011. P values were calculated by chi-squared test. The sum of N does equal the total number of patients for all variables because some items had missing data.

###### Laboratory results of study subjects.

  Characteristics              Pattern identification          P value                                                                                  
  --------------------------- ------------------------ ----------------------- ----------------------- ------------------------ ----------------------- ----------
  WBC (\*10^3^/ml)               3378 (7.52 ± 2.95)       787 (7.2 ± 2.43)       1002 (7.87 ± 3.85)       1111 (7.42 ± 2.40)       478 (7.52 ± 2.62)     \<0.0001
  RBC (\*10^6^/ml)              3313 (4.82 ± 14.48)       771 (4.18 ± 0.53)      987 (5.68 ± 22.91)      1085 (4.75 ± 12.72)       470 (4.26 ± 0.55)      0.1280
  Hg (mmHg)                     3347 (13.35 ± 1.90)      780 (12.79 ± 1.66)      987 (13.89 ± 2.20)      1103 (13.36 ± 1.68)      477 (13.12 ± 1.76)     \<0.0001
  Hct (%)                       3379 (39.39 ± 8.61)      787 (37.76 ± 4.63)     1003 (41.05 ± 13.81)     1110 (39.36 ± 4.82)      479 (38.67 ± 4.89)     \<0.0001
  Platelet (\*10^3^/ml)        3361 (241.32 ± 82.49)    783 (238.81 ± 84.66)    996 (230.14 ± 82.60)    1103 (251.71 ± 76.95)    479 (244.72 ± 87.85)    \<0.0001
  Fibrinogen (mg/dL)           1853 (388.70 ± 170.17)   378 (386.07 ± 164.56)   502 (387.10 ± 224.09)   708 (383.70 ± 132.86)    265 (408.89 ± 146.33)    0.2144
  Total cholesterol (mg/dL)    3275 (184.72 ± 45.42)    750 (185.23 ± 46.67)    968 (179.94 ± 44.87)    1092 (189.78 ± 45.78)    465 (181.98 ± 42.42)    \<0.0001
  Triglyceride (mg/dL)         3104 (155.91 ± 110.02)   703 (149.22 ± 124.71)   916 (159.28 ± 103.53)   1060 (163.53 ± 111.04)   425 (140.69 ± 91.83)     0.0008
  HDL-cholesterol (mg/dL)       2923 (43.79 ± 17.78)     660 (44.62 ± 13.24)     834 (42.79 ± 14.08)     1020 (43.84 ± 23.54)     409 (44.39 ± 13.73)     0.2039
  Total lipid (mg/dL)          834 (537.96 ± 155.26)    146 (525.50 ± 163.70)   203 (524.47 ± 145.35)   399 (560.85 ± 157.84)     86 (484.76 ± 91.83)    \<0.0001
  Na (mmol/L)                   3336 (140.32 ± 5.29)     780 (140.29 ± 6.02)     989 (140.00 ± 5.34)     1096 (140.59 ± 5.26)     471 (140.39 ± 3.73)     0.0913
  K (mmol/L)                     3336 (4.14 ± 3.43)       780 (4.07 ± 0.51)       988 (4.33 ± 5.43)       1096 (4.11 ± 2.99)       472 (3.96 ± 0.45)      0.1885
  Cl (mmol/L)                   3270 (104.38 ± 5.68)     742 (104.62 ± 4.27)     979 (104.18 ± 5.94)     1086 (104.46 ± 6.78)     463 (104.24 ± 3.99)     0.4015
  GOT (U/ml)                    3363 (26.57 ± 22.57)     781 (26.81 ± 36.35)     999 (27.80 ± 17.82)     1107 (25.56 ± 14.99)     476 (25.91 ± 15.48)     0.1274
  GPT (U/ml)                    3361 (24.54 ± 20.87)     780 (22.91 ± 21.89)     999 (26.75 ± 19.87)     1106 (24.47 ± 21.00)     476 (22.77 ± 20.56)    \<0.0001
  BUN (mg/dL)                   3327 (15.18 ± 6.62)      770 (15.52 ± 6.38)      998 (15.07 ± 5.59)      1091 (14.89 ± 7.64)      468 (15.57 ± 6.47)      0.1117
  Cr (mg/dL)                     3296 (1.03 ± 6.83)       765 (0.92 ± 0.82)       984 (0.95 ± 0.70)      1082 (1.24 ± 11.88)       465 (0.91 ± 0.69)      0.6868
  LDH (IU/L)                   2510 (319.32 ± 147.57)   563 (322.30 ± 181.20)   725 (324.21 ± 125.39)   888 (318.99 ± 146.59)    334 (304.54 ± 130.24)    0.2231
  CK (IU/L)                    2270 (101.13 ± 136.26)   519 (98.13 ± 186.10)    611 (115.72 ± 156.99)    834 (93.28 ± 82.36)     306 (98.51 ± 104.31)     0.0174
  FBS (mg/dL)                  2610 (118.37 ± 47.71)    560 (114.61 ± 46.55)    730 (117.61 ± 42.39)     934 (120.15 ± 50.90)    386 (120.87 ± 50.63)     0.1081
  PP2 (mmol/L)                 1446 (170.15 ± 73.21)    271 (166.55 ± 67.59)    406 (163.83 ± 63.41)     537 (172.66 ± 65.28)    232 (179.61 ± 105.18)    0.0421
  Homocysteine (umol/L)         1480 (11.32 ± 6.04)      328 (11.22 ± 5.84)      431 (11.50 ± 5.35)       530 (11.24 ± 6.61)      191 (11.28 ± 6.25)      0.0281
  Vitamine B12 (pg/mL)         938 (663.06 ± 370.32)    162 (684.92 ± 403.21)   270 (611.33 ± 333.16)   403 (673.40 ± 374.10)    103 (723.79 ± 383.28)   \<0.0001
  Folic acid (ng/mL)             946 (9.14 ± 30.54)      166 (11.92 ± 55.42)     275 (9.13 ± 35.97)       400 (8.24 ± 6.14)        105 (8.18 ± 5.39)      0.6098

All results are expressed as N (Mean ± SD). ^1^Collected data from June 2005 to April 2011. WBC: white blood cell. RBC: red blood cell. Hg: hemoglobin. Hct: hematocrit. GOT: glutamate oxaloacetate transaminase. GPT: glutamate pyruvate transaminase. BUN: blood urea nitrogen. Cr: creatinine. LDH: lactate dehydrogenase. CK: creatine kinase. FBS: fasting blood suger. PP2: 2 hours postprandial blood. P values were calculated by ANOVA. The sum of N does equal the total number of patients for all variables because some items had missing data.
